Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.

Saved in:
Bibliographic Details
Title: Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer.
Authors: Addeo A; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland. Electronic address: alfredo.addeo@hcuge.ch., Shah PK; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Bordry N; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Hudson RD; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Albracht B; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Di Marco M; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Kaklamani V; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Dietrich PY; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Taylor BS; Division of Infectious Diseases, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, TX, USA., Simand PF; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Patel D; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Wang J; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Labidi-Galy I; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland; Center of Translational Research in Onco-Hematology, Faculty of Medicine, University of Geneva, Swiss Cancer Center Leman, Geneva, Switzerland., Fertani S; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Leach RJ; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Sandoval J; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Lathrop K; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Mach N; Department of Oncology, Geneva University Hospitals, University of Geneva, Swiss Cancer Center Leman, Switzerland., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA. Electronic address: shahdp@uthscsa.edu.
Source: Cancer cell [Cancer Cell] 2021 Aug 09; Vol. 39 (8), pp. 1091-1098.e2. Date of Electronic Publication: 2021 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-3686
DOI:10.1016/j.ccell.2021.06.009